HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Liu Selected Research

KIR3DS1 Receptors

9/2018[The favorable effects of KIR3DS1 and Bw4(80Ile) on viral set point and CD4 count decline in HIV-1 patients with acutely infected with HIV-1 infection].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Liu Research Topics

Disease

287Neoplasms (Cancer)
05/2022 - 01/2000
99Infections
06/2022 - 01/2000
60Neoplasm Metastasis (Metastasis)
04/2021 - 07/2000
57Inflammation (Inflammations)
06/2022 - 01/2000
45Breast Neoplasms (Breast Cancer)
06/2022 - 08/2000
33Hypoxia (Hypoxemia)
08/2021 - 12/2000
33Carcinogenesis
08/2020 - 03/2000
32Wounds and Injuries (Trauma)
03/2022 - 03/2001
30Lung Neoplasms (Lung Cancer)
04/2022 - 03/2000
29Hepatocellular Carcinoma (Hepatoma)
05/2022 - 01/2000
29Body Weight (Weight, Body)
01/2022 - 01/2000
28Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2006
27Fibrosis (Cirrhosis)
06/2021 - 02/2000
27Carcinoma (Carcinomatosis)
11/2019 - 03/2000
26Hemorrhage
03/2021 - 12/2000
26Ischemia
01/2020 - 01/2000
25Stomach Neoplasms (Stomach Cancer)
05/2022 - 10/2000
25Glioma (Gliomas)
01/2022 - 12/2000
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2021 - 01/2011
24Colorectal Neoplasms (Colorectal Cancer)
04/2021 - 02/2000
22Adenocarcinoma
05/2022 - 04/2000
22Hypertension (High Blood Pressure)
01/2022 - 03/2000
22Infarction (Infarctions)
07/2020 - 01/2000
21Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2000
21Stroke (Strokes)
01/2022 - 05/2000
20Pain (Aches)
01/2022 - 03/2001
20Lymphatic Metastasis
11/2021 - 07/2000
19Brain Ischemia (Cerebral Ischemia)
01/2022 - 04/2000
19Reperfusion Injury
12/2020 - 03/2001
18Myocardial Infarction
12/2021 - 01/2000
18Cataract (Cataracts)
05/2021 - 09/2000
18Insulin Resistance
12/2017 - 06/2001
18Atherosclerosis
03/2016 - 05/2000
17Burns
06/2022 - 04/2000
16Obesity
01/2019 - 03/2000
14Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 12/2001
14Asthma (Bronchial Asthma)
04/2022 - 03/2000
14Melanoma (Melanoma, Malignant)
10/2020 - 10/2000
13Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 04/2001
13Adenocarcinoma of Lung
04/2022 - 03/2000
13Thrombosis (Thrombus)
04/2022 - 05/2012
13Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2018 - 01/2000
13Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2000
12Necrosis
01/2020 - 06/2000
11Nasopharyngeal Carcinoma
01/2022 - 01/2000
11Rheumatoid Arthritis
04/2021 - 10/2007
11Pathologic Constriction (Stenosis)
04/2021 - 06/2000
11Ischemic Stroke
01/2021 - 05/2000
11Cardiovascular Diseases (Cardiovascular Disease)
07/2020 - 07/2000
10Diarrhea
01/2022 - 01/2001

Drug/Important Bio-Agent (IBA)

133Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2000
51Messenger RNA (mRNA)IBA
02/2021 - 01/2000
47CytokinesIBA
01/2021 - 01/2000
39Pharmaceutical PreparationsIBA
11/2021 - 02/2000
39Biomarkers (Surrogate Marker)IBA
09/2021 - 03/2000
38Biological ProductsIBA
12/2021 - 07/2000
38DNA (Deoxyribonucleic Acid)IBA
11/2021 - 01/2000
33MicroRNAs (MicroRNA)IBA
08/2021 - 10/2010
31Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2000
26Long Noncoding RNAIBA
01/2022 - 01/2015
26Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2021 - 01/2000
25LipidsIBA
12/2021 - 03/2000
24AntigensIBA
02/2022 - 05/2000
24AntibodiesIBA
04/2021 - 01/2000
23EnzymesIBA
05/2020 - 01/2000
22RNA (Ribonucleic Acid)IBA
04/2022 - 08/2000
20Transcription Factors (Transcription Factor)IBA
05/2022 - 05/2001
20Peptides (Polypeptides)IBA
02/2022 - 02/2001
19Interleukin-6 (Interleukin 6)IBA
04/2021 - 01/2000
19Small Interfering RNA (siRNA)IBA
01/2020 - 06/2006
18Therapeutic UsesIBA
04/2021 - 01/2000
17LigandsIBA
04/2022 - 02/2001
16Indicators and Reagents (Reagents)IBA
04/2022 - 06/2000
16Hormones (Hormone)IBA
01/2022 - 12/2000
16VaccinesIBA
01/2021 - 02/2000
16Phosphotransferases (Kinase)IBA
12/2020 - 12/2000
16salicylhydroxamic acid (SHAM)IBA
01/2020 - 03/2001
15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 11/2001
14Insulin (Novolin)FDA Link
12/2017 - 02/2000
13Cisplatin (Platino)FDA LinkGeneric
03/2020 - 07/2008
13CateninsIBA
01/2020 - 01/2015
12Interleukin-10 (Interleukin 10)IBA
11/2021 - 08/2000
12Triglycerides (Triacylglycerol)IBA
11/2020 - 03/2000
12VimentinIBA
08/2020 - 08/2000
11C-Reactive ProteinIBA
12/2021 - 03/2005
11CholesterolIBA
09/2021 - 03/2000
11Adenosine Triphosphate (ATP)IBA
08/2020 - 01/2000
11Estrogen ReceptorsIBA
01/2018 - 07/2001
11Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 01/2000
10GlucocorticoidsIBA
04/2022 - 02/2004
10Sirtuin 1IBA
12/2021 - 09/2011

Therapy/Procedure

138Therapeutics
06/2022 - 01/2000
51Drug Therapy (Chemotherapy)
05/2022 - 01/2000
26Radiotherapy
05/2022 - 01/2000
19Transplantation
06/2022 - 06/2000
17Immunotherapy
04/2022 - 05/2000
15Length of Stay
05/2022 - 10/2010
15Aftercare (After-Treatment)
12/2021 - 09/2000
14Stents
04/2022 - 12/2000
10Hematopoietic Stem Cell Transplantation
01/2022 - 06/2009